Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 31

Trial Status

Completed2
Terminated2

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT01758250Completed
Microvascular and Fibrosis Imaging Study
Autoimmune DiseasesChronic Graft Versus Host DiseaseSickle Cell Disease
PrincipalinvestigatorStart date: 2013-02-01
NCT00849745Phase 1Terminated
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Systemic Lupus ErythematosusSystemic Sclerosis
Principalinvestigator
NCT00926575Phase 3Terminated
Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)
Acute Gastrointestinal Graft vs Host Disease
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Adela Cardones, MD

Duke University

Moderately Similar
1 trials

Shared therapeutic areas:

Autoimmune DiseasesChronic Graft-Versus-Host DiseaseAnemia, Sickle Cell

Worked with same sponsors:

Duke University
Collaborated on 1 trial
Similarity Score34%

David Hockenbery, MD

Fred Hutchinson Cancer Center

Related
2 trials

Shared therapeutic areas:

Acute Gastrointestinal Graft vs Host Disease

Worked with same sponsors:

Soligenix
Collaborated on 1 trial
Similarity Score14%

Donald Tashkin, MD

University of California, Los Angeles

Related
2 trials

Shared therapeutic areas:

Scleroderma

Worked with same sponsors:

Duke University
Collaborated on 1 trial
Similarity Score14%

Daniel Furst, MD

University of California, Los Angeles

Related
1 trials

Shared therapeutic areas:

Scleroderma

Worked with same sponsors:

Duke University
Collaborated on 1 trial
Similarity Score14%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

Lupus Erythematosus, SystemicAnemia, Sickle CellScleroderma, Systemic
Similarity Score13%

John F Tisdale, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
17 trials

Shared therapeutic areas:

Anemia, Sickle Cell
Similarity Score4%

Laura DeCastro, MD

Duke University

Related
2 trials

Shared therapeutic areas:

Anemia, Sickle Cell
Similarity Score4%

Xianyun Wang, Doctor

The First Hospital of Hebei Medical University

Related
4 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score4%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Anemia, Sickle Cell
Similarity Score4%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT01758250PrincipalInvestigator

Microvascular and Fibrosis Imaging Study

Autoimmune DiseasesChronic Graft Versus Host DiseaseSickle Cell Disease
Completed
NCT00849745Phase 1PrincipalInvestigator

Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases

Systemic Lupus ErythematosusSystemic Sclerosis
Terminated
NCT00926575Phase 3PrincipalInvestigator

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

Acute Gastrointestinal Graft vs Host Disease
Terminated
NCT01762449StudyChair

Morbidity and Mortality Follow Up for the Scleroderma Lung Study

Scleroderma
Completed

All 4 trials loaded